Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance
(2000) In Diabetic Medicine 17(4). p.259-268- Abstract
Aims: Sorbitol and myo-inositol levels and morphology of sural nerve were compared with nerve function and clinical neuropathy in men with diabetic, impaired (IGT), and normal glucose tolerance. Methods: After neurography of sural nerve and determinations of sensory thresholds for vibration, warm and cold on the foot, whole nerve sural nerve biopsy was performed in 10 men with Type 1 diabetes mellitus, 10 with IGT, and 10 with normal glucose tolerance. Polyol levels were assessed by gas-liquid chromatography/mass spectrometry. Results: Sural nerve amplitudes were significantly lower and sorbitol levels significantly higher in diabetic patients (median (interquartile range)) (3.7 (3.5) μV and 643 (412) pmol/mg protein, respectively) both... (More)
Aims: Sorbitol and myo-inositol levels and morphology of sural nerve were compared with nerve function and clinical neuropathy in men with diabetic, impaired (IGT), and normal glucose tolerance. Methods: After neurography of sural nerve and determinations of sensory thresholds for vibration, warm and cold on the foot, whole nerve sural nerve biopsy was performed in 10 men with Type 1 diabetes mellitus, 10 with IGT, and 10 with normal glucose tolerance. Polyol levels were assessed by gas-liquid chromatography/mass spectrometry. Results: Sural nerve amplitudes were significantly lower and sorbitol levels significantly higher in diabetic patients (median (interquartile range)) (3.7 (3.5) μV and 643 (412) pmol/mg protein, respectively) both compared with IGT (11.3 (10.6) μV; P = 0.04 and 286 (83) pmol/mg protein; P = 0.0032, respectively) and normally glucose tolerant (10.0 (11.6); P = 0.0142 and 296 (250) pmol/mg protein; P = 0.0191, respectively) subjects. There were no differences in nerve morphology between the three groups. Nerve myo-inositol levels correlated, however, positively with cluster density (r(s) = 0.56; P = 0.0054). In diabetic and IGT subjects, sural nerve amplitudes (2.6 (3.8) vs. 12.1 (10.6) μV; P = 0.0246) and myelinated nerve fibre density (MNFD; 4076 (1091) vs. 5219 (668) nerve fibres/mm2; P = 0.0021) were significantly lower in nine subjects with clinical neuropathy than in 10 without. Conclusions: Nerve degeneration (i.e. MNFD) correlated with clinical neuropathy but not with glucose tolerance status whereas nerve myo-inositol levels positively correlated with signs of nerve regeneration (i.e. increased cluster density).
(Less)
- author
- Sundkvist, Göran LU ; Dahlin, L. B. LU ; Nilsson, H. LU ; Eriksson, K. F. LU ; Lindgärde, F. LU ; Rosén, I. LU ; Lattimer, S. A. ; Sima, A. A.F. ; Sullivan, K. and Greene, D. A.
- organization
-
- Department of Clinical Sciences, Malmö
- WCMM-Wallenberg Centre for Molecular Medicine
- Department of Translational Medicine
- Hand Surgery, Malmö (research group)
- Thoracic Surgery
- Translational Muscle Research (research group)
- Vascular Diseases - Clinical Research (research group)
- Cardiovascular Research - Epidemiology (research group)
- Clinical Neurophysiology
- publishing date
- 2000-04
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Human diabetes, IGT, Peripheral nerve function, Sorbitol, Sural nerve
- in
- Diabetic Medicine
- volume
- 17
- issue
- 4
- pages
- 259 - 268
- publisher
- Wiley-Blackwell
- external identifiers
-
- scopus:0034026555
- pmid:10821291
- ISSN
- 0742-3071
- DOI
- 10.1046/j.1464-5491.2000.00261.x
- language
- English
- LU publication?
- yes
- id
- c48d1cf2-467c-4241-8542-52ee2a455ff4
- date added to LUP
- 2019-06-17 14:00:09
- date last changed
- 2024-10-02 04:59:20
@article{c48d1cf2-467c-4241-8542-52ee2a455ff4, abstract = {{<p>Aims: Sorbitol and myo-inositol levels and morphology of sural nerve were compared with nerve function and clinical neuropathy in men with diabetic, impaired (IGT), and normal glucose tolerance. Methods: After neurography of sural nerve and determinations of sensory thresholds for vibration, warm and cold on the foot, whole nerve sural nerve biopsy was performed in 10 men with Type 1 diabetes mellitus, 10 with IGT, and 10 with normal glucose tolerance. Polyol levels were assessed by gas-liquid chromatography/mass spectrometry. Results: Sural nerve amplitudes were significantly lower and sorbitol levels significantly higher in diabetic patients (median (interquartile range)) (3.7 (3.5) μV and 643 (412) pmol/mg protein, respectively) both compared with IGT (11.3 (10.6) μV; P = 0.04 and 286 (83) pmol/mg protein; P = 0.0032, respectively) and normally glucose tolerant (10.0 (11.6); P = 0.0142 and 296 (250) pmol/mg protein; P = 0.0191, respectively) subjects. There were no differences in nerve morphology between the three groups. Nerve myo-inositol levels correlated, however, positively with cluster density (r(s) = 0.56; P = 0.0054). In diabetic and IGT subjects, sural nerve amplitudes (2.6 (3.8) vs. 12.1 (10.6) μV; P = 0.0246) and myelinated nerve fibre density (MNFD; 4076 (1091) vs. 5219 (668) nerve fibres/mm<sup>2</sup>; P = 0.0021) were significantly lower in nine subjects with clinical neuropathy than in 10 without. Conclusions: Nerve degeneration (i.e. MNFD) correlated with clinical neuropathy but not with glucose tolerance status whereas nerve myo-inositol levels positively correlated with signs of nerve regeneration (i.e. increased cluster density).</p>}}, author = {{Sundkvist, Göran and Dahlin, L. B. and Nilsson, H. and Eriksson, K. F. and Lindgärde, F. and Rosén, I. and Lattimer, S. A. and Sima, A. A.F. and Sullivan, K. and Greene, D. A.}}, issn = {{0742-3071}}, keywords = {{Human diabetes; IGT; Peripheral nerve function; Sorbitol; Sural nerve}}, language = {{eng}}, number = {{4}}, pages = {{259--268}}, publisher = {{Wiley-Blackwell}}, series = {{Diabetic Medicine}}, title = {{Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance}}, url = {{http://dx.doi.org/10.1046/j.1464-5491.2000.00261.x}}, doi = {{10.1046/j.1464-5491.2000.00261.x}}, volume = {{17}}, year = {{2000}}, }